IRIS
MONTECUCCO, CARLOMAURIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.435
AS - Asia 14.900
EU - Europa 12.616
SA - Sud America 1.889
AF - Africa 203
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 15
Totale 49.084
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.054
CN - Cina 8.432
SG - Singapore 3.279
IE - Irlanda 3.252
HK - Hong Kong 1.778
UA - Ucraina 1.698
DE - Germania 1.661
BR - Brasile 1.575
RU - Federazione Russa 1.549
FI - Finlandia 1.474
SE - Svezia 862
IT - Italia 764
GB - Regno Unito 585
VN - Vietnam 546
CA - Canada 241
IN - India 209
FR - Francia 207
AR - Argentina 126
JP - Giappone 114
AT - Austria 103
BD - Bangladesh 89
MX - Messico 79
PL - Polonia 77
TR - Turchia 73
BE - Belgio 66
ZA - Sudafrica 65
NL - Olanda 61
EC - Ecuador 60
ES - Italia 60
IQ - Iraq 51
CZ - Repubblica Ceca 48
ID - Indonesia 42
IR - Iran 40
AE - Emirati Arabi Uniti 34
CO - Colombia 33
MA - Marocco 30
LT - Lituania 25
VE - Venezuela 24
SA - Arabia Saudita 23
CL - Cile 21
IL - Israele 21
PK - Pakistan 20
AU - Australia 19
EG - Egitto 18
PY - Paraguay 17
DO - Repubblica Dominicana 16
MU - Mauritius 16
PE - Perù 16
RO - Romania 15
TN - Tunisia 15
UZ - Uzbekistan 15
KE - Kenya 13
LV - Lettonia 13
AZ - Azerbaigian 12
KZ - Kazakistan 12
AL - Albania 11
UY - Uruguay 11
DK - Danimarca 10
DZ - Algeria 10
EU - Europa 10
JO - Giordania 10
KR - Corea 10
NP - Nepal 10
PH - Filippine 10
CR - Costa Rica 9
HU - Ungheria 9
KG - Kirghizistan 9
BG - Bulgaria 8
SN - Senegal 8
BY - Bielorussia 7
CH - Svizzera 7
TH - Thailandia 7
GE - Georgia 6
GR - Grecia 6
MK - Macedonia 6
JM - Giamaica 5
LB - Libano 5
LK - Sri Lanka 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
PA - Panama 5
PS - Palestinian Territory 5
SK - Slovacchia (Repubblica Slovacca) 5
SY - Repubblica araba siriana 5
TT - Trinidad e Tobago 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BA - Bosnia-Erzegovina 4
BO - Bolivia 4
ET - Etiopia 4
HN - Honduras 4
LA - Repubblica Popolare Democratica del Laos 4
NI - Nicaragua 4
OM - Oman 4
PT - Portogallo 4
RS - Serbia 4
BW - Botswana 3
CG - Congo 3
EE - Estonia 3
MD - Moldavia 3
MY - Malesia 3
Totale 49.027
Salva come PNG Salva come JPEG
Città #
Dublin 3.232
Chandler 3.007
Jacksonville 2.265
Nanjing 1.840
Hong Kong 1.771
Dallas 1.636
Ashburn 1.558
Singapore 1.318
Beijing 1.264
Boardman 986
Nanchang 757
Princeton 720
Lawrence 662
Wilmington 620
Helsinki 584
Shenyang 553
Changsha 551
Hebei 539
Los Angeles 488
Medford 471
Munich 435
Jiaxing 426
New York 349
Hangzhou 317
Tianjin 308
Redondo Beach 282
Shanghai 280
Ann Arbor 276
Moscow 276
Buffalo 249
Milan 202
Ho Chi Minh City 189
Woodbridge 145
Turku 144
Pavia 142
São Paulo 142
Houston 141
Norwalk 132
Hanoi 120
Seattle 101
Verona 100
Tokyo 98
Toronto 92
Chicago 91
Fairfield 80
Brooklyn 79
Falkenstein 78
Vienna 73
Warsaw 73
The Dalles 72
Guangzhou 67
Brussels 66
Santa Clara 60
Montreal 59
Zhengzhou 58
London 57
San Francisco 57
Jinan 56
Stockholm 55
Chennai 52
Rio de Janeiro 51
Washington 51
Ningbo 48
Denver 47
Nuremberg 46
Belo Horizonte 43
Boston 43
Columbus 42
Orem 42
Atlanta 41
Pune 41
Johannesburg 39
Phoenix 38
Poplar 38
Frankfurt am Main 37
Kunming 32
Mexico City 32
Ankara 31
Des Moines 31
Porto Alegre 31
Brasília 30
Brno 29
Council Bluffs 28
Manchester 28
Piscataway 28
Quito 25
Taizhou 24
Redwood City 23
Changchun 22
Curitiba 22
Fuzhou 22
Rome 22
Secaucus 22
Haiphong 21
Lanzhou 21
Borås 20
Dubai 20
Amsterdam 19
Campinas 19
Mumbai 19
Totale 32.169
Salva come PNG Salva come JPEG
Nome #
Timing of onset affects arthritis presentation pattern in antisynthetase syndrome 243
Ultrasonographic evaluation of entheses in patients with spondyloarthritis: a systematic literature review 179
Anterior chest wall arthritis and osteitis associated with Sneddon-Wilkinson disease 160
-238 and +489 TNF-alpha along with TNF-RII gene polymorphisms associate with the diffuse phenotype in patients with Systemic Sclerosis. 133
2-DE and LC-MS/MS for a Comparative Proteomic Analysis of BALf from Subjects with Different Subsets of Inflammatory Myopathies 130
Milwaukee shoulder syndrome(artropatia destruente apatite-associata):aspetti terapeutici 129
[Italian Society of Rheumatology (SIR) recommendations for performing arthrocentesis.] 125
Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis. 123
B cells in rheumatoid arthritis. 122
Allopurinol Mouthwashes In Methotrexate-induced Stomatitis 121
[Health-related quality of life in patients with rheumatoid arthritis: assessment by a Italian version of the Arthritis Impact Measurement Scales, Version 2 (AIMS2)]. 121
Assessment of synovitis to predict bone erosions in rheumatoid arthritis 121
BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis 121
B cells in rheumatoid arthritis: from pathogenic players to disease biomarkers 119
DMARDS and infections in rheumatoid arthritis 118
Prevalence of undiagnosed autoimmune rheumatic diseases in the first trimester of pregnancy. Results of a two steps strategy using a self administered questionnaire and autoantibody testing. 117
Prognostic value of antisynthetase antibodies in patients affected by polymiositis/dermatomyositis with interstitial lung disease 116
Antinuclear antibodies in systemic sclerosis 115
A case of adult onset Still's disease treated with infliximab - Reply 114
Characterization of immunoglobulin variable regions of two human pathogenic monoclonal cryocrystalglobulins 112
Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: A European Scleroderma Trials and Research (EUSTAR) analysis 110
Shrinking lung syndrome in sistemic sclerosis 110
Autoantibodies to RNA-polymerases in Italian patients with systemic sclerosis. 109
Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases 109
Anti-neutrophil cytoplasmic antibodies (ANCA) ( Review ) [Anticorpi anticitoplasma dei neutrofili (ANCA)] 109
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine 109
Analysis of Human Myeloma Cell-population Kinetics 108
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. 108
Nailfold capillaroscopy characteristics of antisynthetase syndrome and possible clinical associations: Results of a multicenter international study 108
Proliferation characteristics and polyploidization of cultured myofibroblasts from a patient with fibroblastic rheumatism 107
Nutritional parameters associated with prognosis in non-critically ill hospitalized COVID-19 patients: The NUTRI-COVID19 study 107
Clinical, genetic amd immunologic analysis of a family affected by Ozena. 106
Localized and systemic forms of scleroderma in adults and children. 106
Chemochine linfoidi nella sinovite reumatoide 106
Analysis of the apoliporotein(a) size polymorphism in patients with systemic lupus erythematosus 106
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 106
Interessamento cutaneo nella dermatomiosite 105
Cytokinetic changes in the peripheral blood of leukemic patients during cytostatic therapy. VI. Effect of arabinosylcytosine. 105
Antibodies to cyclic citrullinated peptides in psoriatic arthritis. 105
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 105
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study 105
20 years of experience with tumour necrosis factor inhibitors: what have we learned? 105
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 105
B cells in rheumatoid arthritis. 105
A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica. 104
EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. 104
In early inflammatory polyarthritis more intensive management according to the 2010 ACR/EULAR criteria leads to higher rates of clinical remission: Comparison of two cohorts treated according to different treat to target protocols 104
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus 104
Cobalt hip prosthesis intoxication mimicking an autoimmune disease 104
Is it really infective endocarditis? Distinguishing systemic vasculitis from its mimics 104
Microcytic anemia in rheumatoid arthritis. Relationship with activity and duration of the disease and iron status. 103
[Socio-demographic aspects and therapeutic pathways in patients with rheumatoid arthritis in Italy]. 103
Disease-related malnutrition in systemic sclerosis: Evidences and implications 103
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis 103
Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study 103
Anticyclic citrullinated peptide antibodies as markers of erosive arthritis in antisynthetase syndrome. 102
Diffuse skin reaction after changing the etanercept formulation 102
Multidisciplinary model for hospital-territory integrated management of patient with bone fragility: Primary and secondary prevention of fractures according to severity and complexity 102
A genetic variation located in the promoter region of the UPAR(CD87) gene is associated with the vascular complications of systemic sclerosis. 101
CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis 101
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 101
Cardiovascular comorbidities relate more than others with disease activity in rheumatoid arthritis 101
Lifestyle and dietary habits of patients with gout followed in rheumatology settings 100
Patient preferences in the choice of anti-TNF therapies in rheumatoid arthritis. Results from a questionnaire survey (RIVIERA study). 100
Cytokine profile of bronchoalveolar lavage in systemic sclerosis with interstitial lung disease: comparison with usual interstitial pneumonia 100
Association between anti-dsDNA titre increase and thymoma relapse 99
Soluble HLA-G in pregnancies complicated by autoimmune rheumatic diseases 99
Influenza may influence rheumatoid arthritis 98
TNFalpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunological effects. 98
A Flow Cytometric Study of the Propidium Iodide Staining Kinetics of Human-leukocytes and Its Relationship With Chromatin Structure 98
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus. 98
Mature antigen-experienced helper T cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of rheumatoid joint 98
null 97
Treatment of rheumatoid arthritis with anti-TNF-alpha agents: A reappraisal 97
Life-threatening onset of systemic vasculitis requiring intensive care unit admission: a case series 97
Clinical, genetic and immunologic analysis of a family affected by ozena 96
Ultrasonographic and MRI characterisation of the palindromic phase of rheumatoid arthritis 96
Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis 96
B cell autoimmunity and bone damage in rheumatoid arthritis 96
Impact of delayed diagnoses at the time of COVID-19: Increased rate of preventable bilateral blindness in giant cell arteritis 96
Clinical and experimental evidences of Italian viper venom neurotoxicity. 95
Anterior chest wall arthritis and osteitis associated with Sneddon-Wilkinson disease 95
[Early electroretinografic changes in elderly RA patients treated with hydroxychloroquine] 94
ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis - A EUSTAR analysis 94
Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis 93
Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis 93
Association of RNA Polymerase III Antibodies with Scleroderma Renal Crisis reply 93
G2 synchronization in human acute leukemia after VP 16 213 therapy. 93
Autoantibodies to heterogeneous nuclear ribonucleoproteins. 93
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects]. 93
Janus kinase inhibitors effectively improve pain across different disease activity states in rheumatoid arthritis 92
Cyclophosphamide plus granulocyte colony stimulating factor (G-CSF) is more 92
Anti-Ro(SS-A) 52 kDa and 60 kDa specificities in undifferentiated connective tissue disease 92
Clinical features of ANCA-positive systemic lupus erythematosus: report of two cases. 92
The role of Trimethoprim/sulfametoxazole in reducing relapses and risk of infec-tions in ANCA-associated vasculitis: a meta-analysis 92
[Role of chemokines in the pathogenesis of chronic synovitis during rheumatoid arthritis] 92
Structural features of two monoclonal cryocrystalglobulins causing a rheumatic syndrome with vasculitis. 91
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 91
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from EUSTAR cohort 91
A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica 90
Totale 10.662
Salva come PNG Salva come JPEG
Categoria #
all - tutte 235.823
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 235.823
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.333 0 0 0 0 0 458 40 559 158 525 443 150
2021/20222.729 49 18 71 28 60 93 58 178 148 60 441 1.525
2022/20239.143 1.111 618 87 609 945 914 8 506 3.841 61 241 202
2023/20243.418 408 732 131 238 309 858 105 221 36 119 101 160
2024/20259.508 230 786 167 251 116 460 491 746 2.327 356 1.048 2.530
2025/202610.656 1.636 1.591 2.559 2.172 2.456 242 0 0 0 0 0 0
Totale 50.240